Barriers To Making Acetaminophen Changes Form Basis For Opposition
This article was originally published in The Tan Sheet
Executive Summary
Implementing an FDA working group's recommendations to reduce acetaminophen-induced liver injury poses significant challenges that the drug industry could cite in arguing against potential restrictions